Guindo, Abdoulaye http://orcid.org/0000-0001-8308-1675
Sagara, Issaka
Ouedraogo, Boukary
Sallah, Kankoe
Assadou, Mahamadoun Hamady
Healy, Sara
Duffy, Patrick
Doumbo, Ogobara K.
Dicko, Alassane
Giorgi, Roch
Gaudart, Jean
Funding for this research was provided by:
French Development Agency
Prospective et Coopération
National Institute of Allergy and Infectious Diseases
Rodolphe Mérieux laboratory, Bamako, Mali
Article History
Received: 26 November 2018
Accepted: 21 May 2019
First Online: 15 July 2019
Ethics approval and consent to participate
: Ethical clearance for Vaccine Trial #NCT02334462 (ExternalRef removed registry) was obtained from the ethics committee of the Faculty of Medecine and Denstry & Faculty of pharmacy, Bamako, Mali (letter N°2015_16_FMPOS, February 12, 2015). Individual written consent and authorization were obtained from all participants.
: Not applicable.
: Competing interests are related to Vaccine Trial #NCT02334462 (ExternalRef removed registry). The Rodolphe Mérieux laboratory was the manufacturer of the vaccine. Professor Patrick Duffy, co-author of this article, was appointed by the US National Institute of Health (NIH), which also sponsored the vaccine trial.